Immunotherapy with Keytruda (Pembolizumab) Doctors Abroad — Page 2

Associate Professor Tahsin Ozatli is a specialist medical oncologist at Istinye University Liv Hospital with a focus on targeted therapies for complex cancers.

• Specialises in treatment plans for breast, lung, and gastrointestinal malignancies
• Achieved the rank of Associate Professor in 2016 for his contributions to oncology
• Gained extensive expertise at the dedicated Ankara Oncology Clinic
• Trained at the Regional Training and Research Hospital in Erzurum
• Expert in managing systemic treatments across diverse internal medicine cases

Professor Mustafa Serkan Alemdar is a medical oncology specialist at Medical Park Antalya with deep roots in academic medicine at Akdeniz University.

• Triple-specialised in medicine, internal medicine, and medical oncology
• Served as a senior specialist at Akdeniz University Hospital for over a decade
• Expertise includes modern immunotherapy protocols for complex solid tumours
• Active researcher in the field of clinical oncology and patient outcomes

Professor Irfan Cicin is a senior medical oncologist and academic lead at Trakya University Faculty of Medicine, where he oversees complex cancer treatment protocols.

• Specialised in medical oncology at Trakya University, focusing on modern drug therapies
• Holds the title of Professor of Medical Oncology, the highest academic rank in Turkey
• Served as a physician for the Turkish Air Force Command at Etimesgut Military Hospital
• Practises at İstinye University Liv Hospital Topkapı, a major centre for oncology research
• Expertise includes managing targeted immunotherapy regimes for various solid tumour types

Associate Professor Nail Paksoy is a Board Certified medical oncologist who specialises in immunotherapy and advanced cancer clinical trials.

• ESMO Board Certified in Medical Oncology, recognised by the professional body for oncology in Europe
• Serves as a Sub-Investigator for multiple international clinical trials involving Pembrolizumab (Keytruda)
• Completed a specialised fellowship in Allergy and Immunology, providing deep insight into immune system responses
• Associate Professor at Medipol University, where he contributes to the next generation of cancer specialists

Professor Ercan Ozden is a dual-qualified specialist in internal medicine and medical oncology at VM Medical Park Pendik Hospital.

• Completed the English Medical Programme at Istanbul University Cerrahpasa Faculty of Medicine
• Expert in medical oncology subspecialty focusing on targeted systemic therapies
• Manages complex treatment plans involving immunotherapy for various solid tumours
• Trained at Kocaeli University Faculty of Medicine in advanced oncological care

Associate Professor Muhammed Mustafa Atci is a leading medical oncologist at İstinye University Liv Hospital with a strong focus on advanced immunotherapy protocols.

• Coordinates medical oncology education for the Ministry of Health – teaching the next generation of specialists
• Expert in treating residual triple-negative breast cancer with targeted chemotherapy and immunotherapy combinations
• Active researcher in BRCA mutation profiles and hereditary cancer risks
• Member of the American Society of Clinical Oncology (ASCO) since 2018
• Published extensive research on survival impacts of emerging treatments in international peer-reviewed journals

Associate Professor Ayse Irem Yasin is an ESMO-certified board oncologist who specialises in immunotherapy targets for solid tumours at Medipol Acibadem District Hospital.

• Holds a European Society for Medical Oncology (ESMO) Board Certificate from Paris
• Completed a specialised breast cancer unit residency at Maggiore della Carita Hospital in Italy
• Gained clinical experience at world-leading institutions including Harvard Medical School and Cleveland Clinic
• Expertise covers complex immunotherapy applications for lung, gastrointestinal, and gynaecological cancers